The acute protective effect of a single dose of fluticasone propionate (FP) on the allergen-induced early asthmatic response in man

R. I. Ketchell, M. B. Togher, G. W. Clarke, M. I. Allenby, B. J. O'Connor (London, United Kingdom)

Source: Annual Congress 2002 - Airway reactivity
Session: Airway reactivity
Session type: Thematic Poster Session
Number: 1935
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. I. Ketchell, M. B. Togher, G. W. Clarke, M. I. Allenby, B. J. O'Connor (London, United Kingdom). The acute protective effect of a single dose of fluticasone propionate (FP) on the allergen-induced early asthmatic response in man. Eur Respir J 2002; 20: Suppl. 38, 1935

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In vivo dose response relation of inhaled fluticasone propionate (FP), adults with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 132s
Year: 2004

The effect of single dose montelukast and desloratadine, alone and in combination, on the allergen induced late airway response in atopic asthma
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008



Combined treatment with fluticasone plus salmeterol protects against allergen-induced asthmatic responses better than each drug alone
Source: Eur Respir J 2001; 18: Suppl. 33, 349s
Year: 2001

Effect of switching from high dose fluticasone propionate (FP) to FP/salmeterol (FSC) on airway inflammation in asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 44s
Year: 2004

The effect of fluticasone vs fluticasone plus salmeterol on allergen-induced bronchial inflammation in asthmatic patients. A long-term RCT
Source: Eur Respir J 2004; 24: Suppl. 48, 125s
Year: 2004

Dose-related effect of inhaled fluticasone on allergen-induced airway changes in rats
Source: Eur Respir J 2002; 20: 873-879
Year: 2002



Combined treatment with fluticasone plus salmeterol protects against allergen induced asthmatic responses and subsequent increase in sputum eosinophils
Source: Eur Respir J 2002; 20: Suppl. 38, 189s
Year: 2002

Effect of addition of salmeterol vs doubling the dose of fluticasone propionate on specific airway resistance in children with asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008


The effects of treatment with fluticasone propionate alone and combination with salmeterol on asthma control and airway inflammation
Source: Eur Respir J 2003; 22: Suppl. 45, 287s
Year: 2003

Airway hyperresponsiveness and treatment effectiveness during a one year study of the combination of salmeterol and fluticasone propionate (FP) compared with FP and salmeterol alone in mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 386s
Year: 2002

Effect of an inhaled alpha4-antagonist on the allergen-induced late asthmatic response in patients with mild asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 135s
Year: 2005

Protective effect of inhaled beclomethasone dipropionate (BDP) in asthmatic patients with exercise-induced bronchoconstriction (EIB)
Source: Eur Respir J 2002; 20: Suppl. 38, 306s
Year: 2002

Inhibition of allergen-iduced late asthmatic reaction by montelukast versus fluticasone propionate
Source: Eur Respir J 2003; 22: Suppl. 45, 349s
Year: 2003

Late Breaking Abstract - Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects.
Source: International Congress 2019 – New towards old therapies in airway diseases
Year: 2019



Comparison between fluticasone and salmeterol plus fluticasone on functional responses and sputum eosinophilia induced by allergen challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 123s
Year: 2005

Control of airway inflammation is maintained in asthma patients following a 60% reduction in ICS dose with fluticasone propionate/salmeterol (FSC) compared with higher dose fluticasone propionate (FP) alone
Source: Eur Respir J 2004; 24: Suppl. 48, 308s
Year: 2004

Multiple synergistic effects of fluticasone propionate and salmeterol on T-cell activation in bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 250s
Year: 2004

Tolerance to the protective effect of salmeterol+fluticasone combination (50/250 mcg) on allergen challenge in mild untreated asthmatics
Source: Eur Respir J 2002; 20: Suppl. 38, 388s
Year: 2002

Fluticasone furoate, a novel inhaled corticosteroid (ICS), provides sustained protection against amp airway hyperresponsiveness (AHR) in mild asthma
Source: Annual Congress 2009 - New drugs for airways disease
Year: 2009

Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro
Source: Eur Respir J 2002; 20: Suppl. 38, 91s
Year: 2002